THE VALUE OF ANTI-VEGF DRUGS IN THE TREATMENT OF VARIOUS STAGES OF DIABETIC RETINOPATHY (LITERATURE REVIEW)
loading.default
item.page.date
item.page.journal-title
item.page.journal-issn
item.page.volume-title
item.page.publisher
Scholar Express Journals
item.page.abstract
This article discusses treatments with angiogenesis inhibitors in the complex treatment of diabetic macular edema. A comparative analysis of all types of anti-VGEF drugs on macular edema is given. The use of brolucizumab is described in detail as the most optimal method among anti-VGEF drugs for the management of macular edema. It also provides the latest data with clinically confirmed data on the use of this drug.